Exercise vs Anti-Aging Drugs: Which Strategy Best Fights Musculoskeletal Aging?
Comprehensive review compares natural compounds, synthetic drugs, and exercise for combating age-related bone loss, muscle weakness, and joint degeneration.
Summary
This comprehensive review analyzed 160 studies to compare different strategies for fighting musculoskeletal aging. Researchers examined natural compounds like resveratrol and quercetin, synthetic drugs like rapamycin and dasatinib, and physical exercise. Natural compounds showed promise by activating protective pathways like SIRT1 and reducing inflammation. Synthetic senolytics effectively eliminated harmful senescent cells but raised safety concerns. Exercise emerged as the most promising intervention, directly modulating cellular senescence while improving bone density and muscle function. The authors conclude that combining exercise with targeted compounds may offer the best approach for healthy musculoskeletal aging.
Detailed Summary
As populations age globally, musculoskeletal disorders like osteoporosis, sarcopenia, and osteoarthritis are becoming major health challenges. This comprehensive review analyzed 160 studies to evaluate different strategies for combating age-related decline in bones, muscles, and joints, focusing on cellular senescence as a key driver of these conditions.
The researchers examined three main approaches: natural compounds, synthetic drugs, and physical exercise. Natural compounds like resveratrol showed significant promise by activating the SIRT1/FoxO1 pathway, which promotes bone formation and reduces oxidative stress. In ovariectomized mice, resveratrol treatment for 8 weeks improved bone microarchitecture and increased osteogenic markers including alkaline phosphatase and RUNX2. Quercetin demonstrated dual benefits, improving bone mineral density in osteoporotic rats while enhancing muscle regeneration through IGF-1R/Akt/mTOR signaling pathways.
Synthetic senolytics like dasatinib and quercetin combinations showed effectiveness in eliminating senescent cells, while rapamycin prevented age-related sarcopenia by inhibiting mTORC1. However, rapamycin also reduced bone mineral density in some studies, highlighting the complex trade-offs with pharmaceutical interventions. UBX0101 showed promise for osteoarthritis treatment by selectively targeting senescent joint cells.
Physical exercise emerged as the most compelling intervention, directly modulating cellular senescence pathways targeted by anti-aging compounds. A structured 12-week exercise program significantly reduced senescence markers including p16, p21, and TNF-α. Weight-bearing exercises stimulated mesenchymal stem cell differentiation toward bone-forming osteoblasts, while muscle-derived myokines helped preserve mitochondrial function and slow osteocyte senescence.
The authors conclude that while individual compounds show promise, the complexity of musculoskeletal aging requires integrated approaches. Exercise appears uniquely positioned as both a preventive and therapeutic intervention, potentially enhancing the effects of targeted pharmacological treatments while avoiding their side effects.
Key Findings
- Resveratrol treatment for 8 weeks improved bone microarchitecture and increased osteogenic markers (ALP, RUNX2, osterix) in ovariectomized mice
- Quercetin enhanced bone mineral density and biomechanical properties in osteoporotic rats while promoting muscle cell fusion and migration
- Rapamycin reduced muscle fiber loss in 30-month-old mice by decreasing GDF15 expression and STAT3 phosphorylation
- 12-week structured exercise program significantly reduced senescence markers p16, p21, and TNF-α in human participants
- Curcumin treatment increased bone formation markers and reduced inflammatory cytokines in osteoporotic animal models
- Dasatinib-quercetin combination effectively eliminated senescent cells through regulation of anti-apoptotic processes
- Weight-bearing exercise stimulated mesenchymal stem cell differentiation toward osteoblastic lineage and promoted bone formation
Methodology
This was a comprehensive literature review analyzing 160 articles from MEDLINE database (1945-2025). Studies included both animal models and human clinical trials examining natural compounds, synthetic drugs, and exercise interventions. The review focused on molecular mechanisms, cellular senescence pathways, and clinical outcomes in musculoskeletal aging. No systematic review methodology or meta-analysis was performed.
Study Limitations
This was a narrative review rather than a systematic analysis, potentially introducing selection bias. The authors note that further research is needed on long-term safety, bioavailability, and optimal dosing of senotherapeutic compounds. Many studies were conducted in animal models, limiting direct translation to human applications. The review did not include meta-analysis or quality assessment of included studies.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.